Isolation from a human MDR lung cell line of multiple clonal subpopulations which exhibit significantly different drug resistance

International Journal of Cancer

Volumn 71, Issue 5, 1997, Pages 907-915

  Heenan, Mary ^a   O' Driscoll, Lorraine ^a   Cleary, Irene ^a   Connolly, Lisa ^a   Clynes, Martin ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOSPORIN A; DNA TOPOISOMERASE (ATP HYDROLYSING); DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; VERAPAMIL; VINCRISTINE;

ARTICLE; CELL CLONE; CELL HETEROGENEITY; CELL SUBPOPULATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG SQUAMOUS CELL CARCINOMA; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; TUMOR CELL LINE;

CELL DIVISION; CELL SEPARATION; CLONE CELLS; CYCLOSPORINE; DNA TOPOISOMERASES, TYPE II; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; HUMANS; ISOENZYMES; LUNG NEOPLASMS; P-GLYCOPROTEIN; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; VERAPAMIL;

EID: 0030915004     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970529)71:5<907::AID-IJC33>3.0.CO;2-1     Document Type: Article

References (28)

1. BAILLY, J.D., MULLER, C., JAFFREZOU, J.P., DEMUR, C., CASSAR, G., BORDIER, C. and LAURENT, G., Lack of correlation between expression and function of P-glycoprotein in acute myeloid leukemia cell lines. Leukemia, 9, 799-807 (1995).
2. BARRY, M.A., REYNOLDS, I.E. and EASTMAN, A., Etoposide-induced apoptosis in human HL-60 cells is associated with intracellular acidification. Cancer Res., 53, 2349-2357 (1993).
3. BECK, W.T. and DANKS, M.K., Characteristics of multidrug resistance in human tumor cells. In: I.B. Roninson (ed.), Molecular and cellular biology of multidrug resistance in rumor cells, pp 3-55, Plenum, New York (1991).
4. BECK, W.T., CIRTAIN, M.C., DANKS, M.K., FELSTED, R.L., SAFA, A.R., WOLVERTON, J.S., SUTTLE, D.P. and TRENT, J.M., Pharmacological, molecular and cytosenetic analysis of "atypical" multidrug-resistant human leukemic cells. Cancer Res., 47, 5455-5460 (1987).
5. BOSCOBOINIK, D., GUPTA, R.S. and EPAND, R.M., Investigation of the relationship between altered intracellular pH and multidrug resistance in mammalian cells. Brit. J. Cancer, 61, 568-572 (1990).
6. CLYNES, M., REDMOND, A., MORAN, E. and GILVARRY, U., Multiple drug-resistance in variant of a human non-small cell lung carcinoma cell line. DLKP-A. Cytotechnology, 10, 75-89 (1992).
7. COLE, S.P.C., BHARDWAJ, G., GERLACH, J.H., MACKIE, J.E., GRANT, C.E., ALMQUIST, K.C., STEWART, A.J., KURZ, E.U., DUNCAN, A.M.V. and DEELEY, R.G., Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science, 258, 1650-1654 (1992).
8. DANKS, M.K., SCHMIDT, C.A., CIRTAIN, M.C., SUTTLE, D.P. and BECK, W.T. Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26. Biochemistry, 27, 8861-8869 (1988).
9. FRANKFURT, O.S., SECKINGER, D. and SUGARBAKER, E.V., Intercellular transfer of drug resistance. Cancer Res., 51, 1190-1195 (1991).
10. FRICHE, E., DANKS, M.K., SCHMIDT, C.A. and BECK, W.T., Decreased DNA topoisomerase II in dauno rubicin-resistant Ehrlich ascites tumor cells. Cancer Res., 51, 4213-4218 (1991).
11. GANAPATHI, R. and GRABOWSKI, D., Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluroperazine. Cancer Res., 43, 3696-3699 (1983).
12. HAMADA, H., HAGIWARA, K.I., NAKAJIMA, T. and TSURUO, T., Phosphorylation of the Mr 170,000 to 180,000 glycoprotein specific to multidrug-resistant tumor cells: Effects of verapamil, trifluoroperazine and phorbol esters. Cancer Res., 47, 2860-2865 (1987).
13. HAMILTON, G., COSENTINI, E., TELBKY, B., BISCHOF, G., KOPERNA, T., ZACHERL, J., SCHIESSEL, R. and WENZL, E., Chemosensitisation effect of verapamil and cyclosporin A in vitro is reduced under acidic pH conditions. Europ. J. Cancer, 29A, 1635 (1993).
14. HEPPNER, G.H. and MILLER, B.E., Tumor hetergeneity: biological implications and therapeutic consequences. Cancer Metastasis Rev., 2, 5-23 (1983).
15. JAHDE, E., GLUSENKAMP, K.-H. and RAJEWSKY, M.F., Protection of cultured malignant cells from mitoxantrone cytotoxicity by low extracellular pH: A possible mechanism for chemoresistance in vivo. Europ. J. Cancer, 26, 101-106 (1990).
16. LAW, E., GILVARRY, U., LYNCH, V., GREGORY, B., GRANT, G. and CLYNES, M., Cytogenetic comparison of two poorly differentiated human lung squamous cell carcinoma lines. Cancer Genet. Cytogenet., 59, 111-118 (1992).
17. LOEWENSTEIN, W.R., Junctional intercellular communication: the cell-to-cell membrane channel. Physiol. Rev., 61, 829-913 (1981).
18. MARTIN, A. and CLYNES, M., Comparison of 5 microplate colorimetric assays for in vitro cytotoxicity testing and cell proliferation assays. Cytotechnology, 11, 49-58 (1993).
19. MICKLEY, L.A., BATES, S.E., RICHERT, N.D., CURRIER, S., TANAKA, S., Foss, F., ROSEN, N. and FOJO, A.T., Modulation of the expression of a multidrug resistance gene (mdr-1/P-alycoprotein) by differentiating agents. J. biol. Chem., 264, 18031-18040 (1989).
20. Moscow, J.A. and DIXON, K.H., Glutathione-related enzymes, glutathione and multidrug resistance. Cytotechnology, 12, 155-170 (1993).
21. NEGRI, C. CHIESA, R., CERINO, A., BESTAGNO, M., SALA, C., ZINI, N., MARALDI, N. and ASTALDI-RICCOTTI, G., Monoclonal antibodies to human DNA topoisomerase I and two isoforms of DNA topoisomerase II: 170- and 180- KDa isozymes. Exp. Cell Res., 200, 452-459 (1992).
22. O'DRISCOLL, L., DALY, C., SALEH, M. and CLYNES, M., The use of reverse transcriptase-polymerase chain reaction (RT-PCR) to investigate specific gene expression in multidrug-resistant cells. Cytotechnology, 12, 289-314 (1993).
23. PELLETIER, H., MILLOT, J.-M., CHAUFFERT, B., MANFAIT, M., GENNE, P. and MARTIN, F., Mechanisms of resistance of confluent human and rat colon cancer cells to amhracyclines: Alterations of drug passive diffusion. Cancer Res., 50, 6626-6631 (1990).
24. ROMNSON, I.B., CHIN, J.E., CHOI, K., GROS, P., HOUSEMAN, D.E., FAJO, A., SHEN, D., GOTTESMAN, M.M. and PASTAN, I., Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc. nat. Acad. Sci. (Wash.), 83, 4538-4542 (1986).
25. SCHEPER, R.J., BROXTERMAN, H.J., SCHEFFER, G.L., KAAIJK, P., DALTON, W.S., VAN HEIJNINGEN, T.H.M., VAN KALKEN, C.K., SOLVAK, M.L., DE VRIES, E.G.E., VAN DER VALK, P., MEIJER, C.J.L.M. and PINEDO, M., Overexpression of a Mr 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res., 53, 1475-1479 (1993).
26. SIMON, S., ROY, D. and SCHINDLER, M., Intracellular pH and the control of multidrug resistance. Proc. nat. Acad. Sci. (Wash.), 91, 1128-1132 (1994).
27. YANG, L.-Y., TRUILLO, J.M., SICILIANO, M.J., KIDO, Y., SIDDIK, Z.H. and SU, Y.-Z., Distinct P-glycoprotein expression in two subclones simultaneously selected from a human colon carcinoma cell line by cis-diamminedichloroplatinum (II). Int. J. Cancer, 53, 478-185 (1993).
28. ZHAO, J.-Y. SAVARAJ, N., SONG, R., PRIEBE, W. and KUO, M.T. Overexpression of P-glycoprotein but not its mRNA in multidrug resistant cells selected with hydroxyrubicin. Anticancer Res., 14, 1735-1742 (1994).